Tuesday, July 27, 2010

Teva Profit Rises 32% on Higher US Generic-Drug Sales, Copaxone Revenue - Bloomberg http://www.pharmainfo.net/generic-drug-news/07/27/2010/teva-profit-rises-32-higher-us-generic-drug-sales-copaxone-revenue-bloo

No comments:

Post a Comment